comparemela.com

Latest Breaking News On - மூலக்கூறு நோயியல் ஆய்வகம் - Page 1 : comparemela.com

BD Announces Industry-First CE Marked Assay for HPV Screening from At-Home Self-Collected Vaginal Samples

Share this article Share this article FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry s first self-collection claim for HPV screening has been CE marked to the IVD directive 98/79/EC. The new claim allows laboratories and facilities to process self-collected samples via a BD diluent tube using the BD Onclarity™ HPV Assay on either the BD Viper™ LT or the BD COR™ System. The BD Viper™ LT is in use globally and the BD COR™ System, launched last year, is in use across Europe. BD Onclarity™ HPV Assay 3-Well PCR Reagent Wells

A Race Against the Virus: Creating a COVID Test In Just 19 Days

Behind the scenes, UC Davis researchers started from scratch by Lisa Howard April 19, 2021 In January 2020, Nam Tran and his colleagues in the UC Davis Department of Pathology and Laboratory Medicine were scaling up testing platforms for seasonal influenza and the common cold.  The UC Davis Health Specialty Testing Center Lab team developed COVID-19 testing capable of performing more than 1,000 tests per day. Tran is a professor of clinical pathology at the UC Davis School of Medicine. He was following reports out of China about a mysterious new respiratory virus, SARS-CoV-2. Not much was known at the time about how the novel coronavirus spread or what the mortality rate was.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.